Could a diet rich in omega-3 help #prostatecancer patients and those at risk? A new study published in Nature Communications explores the gut #microbiome and #cancer crosstalk, and the role of polyunsaturated long-chain fatty acids. #pcsm https://lnkd.in/gHiNNdxH
Exosome Diagnostics, a Bio-Techne brand
Biotechnology Research
Waltham, MA 7,783 followers
ExoDx Prostate is the only exosome-based, non-DRE, simple urine test to assess risk for HGPCa and guide biopsy decision.
About us
Exosome Diagnostics, Inc. is commercializing minimally invasive molecular diagnostics in blood and urine to enable doctors to select optimal therapies for cancer and other diseases. Exosomes are lipid bilayer covered microvesicles shed by solid tumors into body fluids, such as blood and urine. Exosomes contain nucleic acid profiles of cancers and other diseases. In published studies, Exosome Diagnostics has demonstrated the ability to extract exosomes from the blood and urine of patients, and to detect with high sensitivity and specificity key genes and gene mutations associated with a variety of cancers.
- Website
-
http://www.exosomedx.com
External link for Exosome Diagnostics, a Bio-Techne brand
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Waltham, MA
- Type
- Privately Held
- Founded
- 2008
- Specialties
- exosomes and microvesicles, biomarkers, diagnostic development, and biofluids
Locations
-
Primary
266 Second Ave, Suite 200
Waltham, MA 02451, US
-
1000 Westgate Drive
Suite 117
St. Paul, MN 55114, US
-
Am Klopferspitz 19
Martinsried, 82152, DE
Employees at Exosome Diagnostics, a Bio-Techne brand
Updates
-
“The impact of precision medicine in prostate cancer has been significant over a relatively brief period.” Leonard G. Gomella of Sidney Kimmel Comprehensive Cancer Center at Jefferson tells #NYGU #prostatecancer conference. Read more on the Cancer Network site: https://bit.ly/4dAzqqI
Data Support Impact of Precision Medicine in Managing Prostate Cancer
cancernetwork.com
-
The Boston ZERO Prostate Cancer Walk is happening this Sunday, September 8th! If you can't attend, you can still contribute by donating- https://bit.ly/3Z9Sxni Event Details: • Date: Sunday, September 8, 2024 • Location: Newton City Hall (1000 Commonwealth Ave, Newton) • Distance: 5K or 1 Mile Walk Schedule: o 7:30 AM – Registration o 8:30 AM – Opening Ceremony, Run/Walk follows
Support Team Exosome Diagnostics
support.zerocancer.org
-
Are increasing diagnostic costs after PSA screening undermining patient care? A new study explores the issue: https://bit.ly/470rvAQ Find out how the #ExoDx Prostate Test could help you decide if you need further procedures, and about the #ExoCARES program to help navigate costs: https://bit.ly/46VEFio
-
Prostate cancer impacts many lives, but early detection can make a significant difference. Engage in proactive health conversations with your doctors and loved ones about screening options, and stay informed about prostate health. #ProstateCancerAwareness #HealthMatters #EarlyDetection https://bit.ly/3yPiPQW
-
"Ensuring equal access to genomic tumor testing & #precisionmedicine treatments may be a viable strategy to help...#prostatecancer outcomes" Dr. Luca F. Valle tells Urology Times. Read about his #ASCO24 study: https://bit.ly/3T12YWq
Study reinforces value of precision medicine in prostate cancer
urologytimes.com
-
How can physicians partner with their #prostatecancer patients to help them make the decisions that are right for them? This study from David Geffen School of Medicine at UCLA exploring treatment decision-making from the patient perspective provides insights to inform doctors. https://bit.ly/3MirZsw #pcsm #PCAM
-
Explore the benefits and limitations of biomarkers with Dr. Albala on a new episode of The Dr. Geo Podcast https://lnkd.in/gG2ZviU4 #prostatecancer #biomarkers #podcasts
-
They're a population at higher risk of #prostatecancer, yet a new study suggests they are not getting the same quality of care. See what else was revealed in the 10-year scoping review into practice patterns & patient experience among US #veterans. #pcsm https://lnkd.in/gzHfRjyW
Practice Patterns and Patient Experience of Care Among US... : JU Open Plus
journals.lww.com
-
How has the #prostatecancer space evolved in recent years? Northwestern Medicine professors Maha Hussain, MD, & Sarah Fenton, MD, PhD, speak with Cancer Network about changes in research & trial funding, treatment options, and survival outcomes #pcsm https://lnkd.in/eya4Pcru
Observing the Evolving Prostate Cancer Landscape and Hopes for the Future
cancernetwork.com